In this interview, Erik Magnus Ohman, John W. Eikelboom, and Deepak L. Bhatt discuss the primary results from the COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial.

Subscribe on iTunes | Subscribe on Google Play | Subscribe to ACCEL

Keywords: Anticoagulants, Secondary Prevention, Primary Prevention, Angina, Stable, Vascular Diseases, Coronary Artery Disease, Peripheral Arterial Disease, Aspirin, ACCELLite

< Back to Listings